Featured

New trial data suggest dietary fiber supplementation may lower systolic blood pressure in adults with type 2 diabetes and hypertension.

Discover how exercise timing in type 1 diabetes, meal timing, insulin on board, and workout intensity can influence glucose responses.

New research challenges assumptions about the exocrine pancreas in type 2 diabetes and what pancreatic findings may mean for clinical care.

Discover how red blood cell lifespan and biology can affect A1C results, explaining why similar glucose levels may produce different A1C readings.

Peripheral artery disease (PAD) affects millions of people with type 2 diabetes worldwide, increasing the risk of cardiovascular events and limb loss. With recent research into incretin‑based therapies, particularly glucagon‑like peptide‑1 receptor agonists (GLP‑1s), clinicians are asking whether these drugs can improve outcomes in PAD patients treated with GLP‑1s, beyond …

What if the key to resolving both diabetes and liver disease lies in a single therapeutic approach? As rates of metabolic dysfunction-associated steatohepatitis (MASH) rise among people with type 2 diabetes, many clinicians are rethinking how they prioritize treatment. Rather than treating glucose and liver health in silos, combining therapies …

Imagine managing type 1 diabetes and still gaining weight despite careful insulin use, exercise, and carb counting. That’s the frustrating reality for many people living with T1D and obesity. While insulin is life-saving, it can also promote weight gain, making the balance between glucose control and healthy weight even harder. …

Artificial intelligence (AI) is transforming many aspects of diabetes care, and smart insulin management powered by AI is quickly becoming one of its most promising innovations. Tools that read continuous glucose monitor (CGM) data and suggest insulin changes are rapidly entering clinical use. But while these tools are powerful, they …

Menopause marks a major transition in a woman’s life, defined not only by the end of menstrual cycles but also by profound hormonal and metabolic changes. One often under‑recognized shift is the acceleration of cardiometabolic risk. Women in midlife frequently experience increased central adiposity, changes in glucose regulation, rising blood …

Asthma is a chronic inflammatory disease of the airways that affects millions worldwide and often overlaps with metabolic conditions such as obesity and type 2 diabetes. Recently, interest has grown in whether glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs)—a class of drugs commonly used to manage diabetes and obesity—could help reduce …